Infosys Technologies Limited would design and implement the Research Informatics System (RISE) at Elan Pharmaceuticals, Inc, a leading biotechnology company, to accelerate discovery research using a co-creation engagement model that leverages Infosys’ existing intellectual property in this field.
RISE will leverage Infosys’ Scientific Innovation Solution for knowledge collaboration, novel ways to unlock disparate data spread across in-house research labs and other commercial or public sources which will be presented to scientists in context of their research needs, a company press release said.
The co-creationmodel would enable Infosys retain ownership of co-developed IP as part of the implementation.
Posts
No comments:
Post a Comment